M.D. Anderson Cancer Center: all 3,044 studies

Page 6 of 31. Open to participants first (578), then studies with results posted, then the rest; newest registration first within each.

• MSC-DNX-2401 in Treating Patients With Recurrent High-Grade GliomaRecruitingNCT03896568Phase 1
• CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic LeukemiaRecruitingNCT03896269Phase 1
• Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their CaregiversRecruitingNCT03892993Not applicable
• Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain TumorsRecruitingNCT03830151Phase 1
• Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerRecruitingNCT03819296Phase 1
• LET Optimized IMPT in Treating Pediatric Patients With EpendymomaRecruitingNCT03750513Phase 1
• Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene MutationRecruitingNCT03683433Phase 2
• Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic SyndromeRecruitingNCT03661307Phase 1/2
• Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing ChemotherapyRecruitingNCT03630991Phase 1
• Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid LeukemiaRecruitingNCT03629171Phase 2
• iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D MutationRecruitingNCT03608631Phase 1/2
• Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTFRecruitingNCT03604315Phase 1
• Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal CancerRecruitingNCT03594630Early Phase 1
• Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood CancersRecruitingNCT03589729Phase 2
• Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid LeukemiaRecruitingNCT03586609Phase 2
• Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of RecurrenceRecruitingNCT03583710Phase 3
• Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic MalignanciesRecruitingNCT03471260Phase 1/2
• Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural EffusionsRecruitingNCT03465774
• Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral MalignanciesRecruitingNCT03458676Not applicable
• Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related DiseaseRecruitingNCT03425526Phase 1
• Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung CancerRecruitingNCT03422302Not applicable
• Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT StudyRecruitingNCT03408353
• Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource UtilizationRecruitingNCT03407469
• Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic SyndromeRecruitingNCT03383575Phase 2
• Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic CancerRecruitingNCT03295227Phase 1
• Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic LeukemiaRecruitingNCT03263572Phase 2
• Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid LeukemiaRecruitingNCT03214562Phase 1/2
• Measuring Surgical Recovery After Radical CystectomyRecruitingNCT03193970
• Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric CancerRecruitingNCT03161522Phase 2
• Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the BodyRecruitingNCT03145077Not applicable
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/LeukemiaRecruitingNCT03136146Phase 2
• Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal CancerRecruitingNCT03114462Phase 1
• Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational StudiesRecruitingNCT03099850
• Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary MetastasesRecruitingNCT03093909Phase 1
• Establishment of a Parathyroid Tissue BankRecruitingNCT03051126
• Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal DiseaseRecruitingNCT03050762
• Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 PatientsRecruitingNCT03048266
• Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid TumorsRecruitingNCT03039439
• Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck CancerRecruitingNCT03010150
• Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic TherapyRecruitingNCT02945579Not applicable
• Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast CancerRecruitingNCT02918474Not applicable
• Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic LeukemiaRecruitingNCT02877303Phase 2
• Molecular Basis for Variations in Hereditary Colorectal Cancer SyndromesRecruitingNCT02863172
• Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain TumorsRecruitingNCT02754544Not applicable
• Personalized NK Cell Therapy in CBTRecruitingNCT02727803Phase 2
• Observational Prospective Research Study In Monoclonal Gammopathies leadINg to MyelomaRecruitingNCT02726750
• Couple-Based Meditation for Metastatic Lung Cancer Patients and Their PartnersRecruitingNCT02596490Not applicable
• Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC VirusRecruitingNCT02479698Phase 2
• Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory FailureRecruitingNCT02464696Not applicable
• Compassionate Access of the Miltenyi Device for CD34+ Cell SelectionRecruitingNCT02438904Not applicable
• PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid LeukemiaRecruitingNCT02390635Phase 1
• Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary CancerRecruitingNCT02361320Not applicable
• Prospective Study of Colon Serrated PolypsRecruitingNCT02332785
• Prospective Study of Colonoscopic Resection of Large Polyps and Flat LesionsRecruitingNCT02332772
• PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and TestingRecruitingNCT02282969
• Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid LeukemiaRecruitingNCT02115295Phase 2
• Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal CancerRecruitingNCT02107105
• Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy ProgramRecruitingNCT01772771
• Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or NilotinibRecruitingNCT01746836Phase 2
• The Collection and Storage of Umbilical Cord Blood for TransplantationRecruitingNCT01728545
• Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic SyndromeRecruitingNCT01624805Phase 2
• Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)RecruitingNCT01515527Phase 2
• Long-Term Follow-Up of Recipient of Gene Transfer ResearchRecruitingNCT01492036
• Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic LeukemiaRecruitingNCT01409161Phase 2
• Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic LeukemiaRecruitingNCT01371630Phase 1/2
• Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"RecruitingNCT01365169Not applicable
• Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing SurgeryRecruitingNCT01269190Not applicable
• Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton TherapyRecruitingNCT00991094
• Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical TrialRecruitingNCT00816114
• Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeRecruitingNCT00801489Phase 2
• Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk WomenRecruitingNCT00539162Not applicable
• Psychophysical Studies of Cancer Therapy PainRecruitingNCT00515060
• New Assessment System in Measuring Symptom Distress in Cancer PatientsRecruitingNCT00505245
• Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaRecruitingNCT00501826Phase 2
• A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative OutcomesRecruitingNCT00493688
• Data Collection for Patients With Low Grade Ovarian or Peritoneal TumorsRecruitingNCT00488878
• Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast CancerRecruitingNCT00477100
• Cladribine and Rituximab in Treating Patients With Hairy Cell LeukemiaRecruitingNCT00412594Phase 2
• Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Squamous Cell CarcinomaTerminatedNCT06046482Phase 2Results posted
• Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral TherapyTerminatedNCT05717400Phase 4Results posted
• EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian CancerActive, not recruitingNCT05715216Phase 2Results posted
• A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical CarcinomaTerminatedNCT05634577Phase 2Results posted
• Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBLTerminatedNCT05464836Phase 2Results posted
• Implementation of Digital Vital Sign Monitoring to Decrease Sleep Interruption and Enhance Recovery in Phase II of the PROmoting Sleep, Patient Engagement and Recovery (PROSPER) ProjectTerminatedNCT05456360Phase 2/3Results posted
• Intraoperative Aromatherapy Versus Placebo for Port-a-Cath Placement Under Monitored Anesthesia Care. A Randomized Controlled TrialCompletedNCT05328973Phase 2Results posted
• Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis TestTerminatedNCT05243641Phase 1/2Results posted
• Positive Activities for Asian American Cancer Patients and CaregiversCompletedNCT05203614Not applicableResults posted
• Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung CancerActive, not recruitingNCT05144542Not applicableResults posted
• Off-the-shelf NK Cells + SCT for Myeloid MalignanciesCompletedNCT05115630Phase 2Results posted
• Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN AlterationsTerminatedNCT05082025Phase 2Results posted
• IMRT Followed by Pembrolizumab in the Adjuvant Setting in Anaplastic Cancer of the Thyroid (IMPAACT): Phase II Trial Adjuvant Pembrolizumab After IMRT in ATCTerminatedNCT05059470Phase 2Results posted
• A Behavioral Activation Prenatal and Postpartum Intervention for Depressed Pregnant SmokersActive, not recruitingNCT05044546Not applicableResults posted
• Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast CancerTerminatedNCT05041101Phase 1/2Results posted
• A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial CarcinomaTerminatedNCT05036681Phase 2Results posted
• Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second OpinionCompletedNCT05036083Not applicableResults posted
• Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaTerminatedNCT05032183Phase 1/2Results posted
• Feasibility of Digital Thermal Monitoring to Assess Endothelium-Dependent Vasodilation in Patients Undergoing Hematopoietic Cell Transplantation (HCT)TerminatedNCT05029752Not applicableResults posted
• Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer StudyTerminatedNCT05026736Phase 2Results posted
• Sintilimab in Cancer of Unknown PrimaryCompletedNCT05024968Phase 2Results posted
• Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer StudyTerminatedNCT05017103Phase 2Results posted

← M.D. Anderson Cancer Center overview and focus areas